Kkr Genetic Disorder L.p. - Net Worth and Insider Trading
Kkr Genetic Disorder L.p. Net Worth
The estimated net worth of Kkr Genetic Disorder L.p. is at least $684 Million dollars as of 2024-11-10. Kkr Genetic Disorder L.p. is the 10% Owner of BridgeBio Pharma Inc and owns about 25,260,971 shares of BridgeBio Pharma Inc (BBIO) stock worth over $684 Million. Details can be seen in Kkr Genetic Disorder L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kkr Genetic Disorder L.p. has not made any transactions after 2024-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kkr Genetic Disorder L.p.
Kkr Genetic Disorder L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kkr Genetic Disorder L.p. owns 1 companies in total, including BridgeBio Pharma Inc (BBIO) .
Click here to see the complete history of Kkr Genetic Disorder L.p.’s form 4 insider trades.
Insider Ownership Summary of Kkr Genetic Disorder L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2024-09-13 | 10 percent owner |
Kkr Genetic Disorder L.p. Latest Holdings Summary
Kkr Genetic Disorder L.p. currently owns a total of 1 stock. Kkr Genetic Disorder L.p. owns 25,260,971 shares of BridgeBio Pharma Inc (BBIO) as of September 13, 2024, with a value of $684 Million.
Latest Holdings of Kkr Genetic Disorder L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2024-09-13 | 25,260,971 | 27.09 | 684,319,704 |
Holding Weightings of Kkr Genetic Disorder L.p.
Kkr Genetic Disorder L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Kkr Genetic Disorder L.p. has made a total of 3 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 5,800,000 shares on September 13, 2024, which brought Kkr Genetic Disorder L.p. around $149 Million.
Insider Trading History of Kkr Genetic Disorder L.p.
- 1
Kkr Genetic Disorder L.p. Trading Performance
GuruFocus tracks the stock performance after each of Kkr Genetic Disorder L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kkr Genetic Disorder L.p. is -23.64%. GuruFocus also compares Kkr Genetic Disorder L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kkr Genetic Disorder L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kkr Genetic Disorder L.p.'s insider trading performs compared to the benchmark.
Performance of Kkr Genetic Disorder L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.48 | | | | | |
| Relative Return to S&P 500(%) | 8.84 | | | | | |
Kkr Genetic Disorder L.p. Ownership Network
Ownership Network List of Kkr Genetic Disorder L.p.
Ownership Network Relation of Kkr Genetic Disorder L.p.
Kkr Genetic Disorder L.p. Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Kkr Genetic Disorder L.p. is the 10 percent owner of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include director & See Remarks Neil Kumar , See Remarks Brian C Stephenson , and Chairman of Oncology Frank Mccormick .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Kkr Genetic Disorder L.p. made 1 insider transaction in BridgeBio Pharma Inc (BBIO) with a net sale of 5,800,000. Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 12,000 shares made by Randal W Scott , a net sale of 182,045 shares made by Neil Kumar , and a net sale of 73,947 shares made by Brian C Stephenson .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 7,676,737 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,676,737 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Kkr Genetic Disorder L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Kkr Genetic Disorder L.p.. You might contact Kkr Genetic Disorder L.p. via mailing address: C/o Kohlberg Kravis Roberts & Co. L.p., 9 West 57th Street, Suite 4200, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
